Topical Iodine Can Cause Overestimation of Blood Glucose

This article originally appeared here.
Share this content:
Topical Iodine Can Cause Overestimation of Blood Glucose
Topical Iodine Can Cause Overestimation of Blood Glucose

FRIDAY, Aug. 12, 2016 (HealthDay News) -- Use of topical iodine can cause overestimation of blood glucose (BG) readings, according to a case report published online Aug. 8 in the Journal of Clinical Pharmacy and Therapeutics.

A.M. Lipshutz, Pharm.D., from Mount Carmel West Hospital in Columbus, Ohio, and Emily M. Hawes, Pharm.D., from the University of North Carolina in Chapel Hill, present a case of a clinically relevant probable drug-device interaction between topical iodine and a point-of-care glucometer in a 28-year-old pregnant woman of Chinese descent. On diagnosis of gestational diabetes, the woman was instructed to begin self-monitored BG testing four times daily. She felt the readings were inaccurate, varying from 107 to 160 mg/dL within a five- to 10-minute period. At a clinic visit with a pharmacist, the patient's technique was shown to be appropriate.

On thorough interview of the patient it was discovered that she had been using 10 percent povidone-iodine solution administered to the testing site before testing. The patient was asked to wash her hands with soap and water before testing, resulting in more consistent readings on two point-of-care devices. Following appropriate handwashing techniques, there were no further aberrant BG readings. After discontinuing iodine, all readings remained below her goal throughout pregnancy.

"In patients [who] have aberrant or variable BG readings, providers should investigate for improper testing technique," the authors write.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters


More in Home

USPSTF Urges Abuse Screening for Reproductive-Aged Women

USPSTF Urges Abuse Screening for Reproductive-Aged Women

Evidence lacking for assessing balance of benefits, harms of screening for abuse of seniors, vulnerable

Five-Day Nitrofurantoin Beats Single-Dose Fosfomycin for UTI

Five-Day Nitrofurantoin Beats Single-Dose Fosfomycin for UTI

Increased likelihood of clinical and microbiological resolution for uncomplicated UTI in women

Exercise Intervention Doesn't Improve Walking Ability in PAD

Exercise Intervention Doesn't Improve Walking Ability in PAD

Smaller mean change from baseline to follow-up in 6-minute walking distance with exercise intervention

is free, fast, and customized just for you!

Already a member?

Sign In Now »